These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2561149)

  • 1. Nadolol prevents the exercise-induced rise in lymphocyte beta-receptor number in borderline hypertension.
    Terzoli L; Bragato R; Bolla GB; Leonetti G; Zanchetti A
    J Hypertens Suppl; 1989 Dec; 7(6):S46-7. PubMed ID: 2561149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of a submaximal physical load on the beta 2-adrenoreceptor-dependent adenylate cyclase system of the lymphocytes in hypertension].
    Aripova NA; Parfenova EV; Bosykh EG; Naumann E; Krasnikova TL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):46-54. PubMed ID: 2557857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nadolol on hemodynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension.
    Jimenez AH; Tofler GH; Chen X; Stubbs ME; Solomon HS; Muller JE
    Am J Cardiol; 1993 Jul; 72(1):47-52. PubMed ID: 8517427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enalapril versus combined enalapril and nadolol treatment: effects on blood pressure, heart rate, humoral variables, and plasma potassium at rest and during exercise in hypertensive patients.
    Sullivan PA; Daly B; O'Connor R
    Cardiovasc Drugs Ther; 1992 Jun; 6(3):261-5. PubMed ID: 1637731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs.
    Liang CS; Frantz RP; Suematsu M; Sakamoto S; Sullebarger JT; Fan TM; Guthinger L
    Circulation; 1991 Jul; 84(1):254-66. PubMed ID: 1676348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the characteristics of the lymphocyte beta 2-adrenoreceptors under the influence of prostaglandin E2 infusions in hypertension patients].
    Minchuna VP; Krasnikova TL; Runikhin AIu; Svet EA; Stareev VE
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):54-8. PubMed ID: 2557858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
    Wilcox RG; Hampton JR
    Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of lymphocyte beta-adrenoceptors in essential hypertension: effects of propranolol treatment and dynamic exercise.
    Parfyonova EV; Korichneva IL; Suvorov YI; Krasnikova TL
    Health Psychol; 1988; 7 Suppl():33-52. PubMed ID: 2854050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increase in the lymphocyte beta-adrenergic receptor population during physical exercise].
    Brevetti G; Leone R; Caracciolo G; Perna S; Rossini A
    G Ital Cardiol; 1990 Jan; 20(1):20-3. PubMed ID: 2158469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nadolol versus diltiazem and combination for preventing exercise-induced ischemia in severe angina pectoris.
    Miller WE; Vittitoe J; O'Rourke RA; Crawford MH
    Am J Cardiol; 1988 Sep; 62(7):372-6. PubMed ID: 3414514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cardiac beta 2-receptors in cardiac responses to exercise in cardiac transplant patients.
    Leenen FH; Davies RA; Fourney A
    Circulation; 1995 Feb; 91(3):685-90. PubMed ID: 7828294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of nadolol to determine its effect on ambulatory blood pressure over 24 hours, and during exercise testing.
    Hornung RS; Gould BA; Kieso H; Raftery EB
    Br J Clin Pharmacol; 1982 Jul; 14(1):83-8. PubMed ID: 6125200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic exercise-induced increase in lymphocyte beta-2-adrenoceptors: abnormality in essential hypertension and its correction by antihypertensives.
    Brodde OE; Daul AE; Wang XL; Michel MC; Galal O
    Clin Pharmacol Ther; 1987 Apr; 41(4):371-9. PubMed ID: 3030607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of exercise on triacylglycerol metabolism in fasted, untrained rats treated with nadolol.
    Paulin A; Deshaies Y
    Physiol Behav; 1991 Oct; 50(4):681-7. PubMed ID: 1663625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma catecholamines following exercise in hypertensives treated with pindolol: comparison with placebo and metoprolol.
    Vandongen R; Margetts B; Deklerk N; Beilin LJ; Rogers P
    Br J Clin Pharmacol; 1986 Jun; 21(6):627-32. PubMed ID: 3741714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential exercise effects of captopril and nadolol in patients with essential hypertension.
    Kostis JB; Shindler DM; Moreyra AE; Ruddy MC; Schneider S; Cosgrove N
    Angiology; 1992 Aug; 43(8):647-52. PubMed ID: 1632567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic receptor blockade during exercise decreases intestinal lymphocyte apoptosis but not cell loss in mice.
    Marra S; Hoffman-Goetz L
    Can J Physiol Pharmacol; 2004 Jul; 82(7):465-73. PubMed ID: 15389293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.